Hemeryck A - Search Results

1

The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis.

Van Roy M, Ververken C, Beirnaert E, Hoefman S, Kolkman J, Vierboom M, Breedveld E, 't Hart B, Poelmans S, Bontinck L, Hemeryck A, Jacobs S, Baumeister J, Ulrichts H. Van Roy M, et al. Among authors: hemeryck a. Arthritis Res Ther. 2015 May 20;17(1):135. doi: 10.1186/s13075-015-0651-0. Arthritis Res Ther. 2015. PMID: 25994180 Free PMC article.

2

Pharmacokinetics, metabolism, excretion and plasma protein binding of 14C-levofloxacin after a single oral administration in the Rhesus monkey.

Hemeryck A, Mamidi RN, Bottacini M, Macpherson D, Kao M, Kelley MF. Hemeryck A, et al. Xenobiotica. 2006 Jul;36(7):597-613. doi: 10.1080/00498250600674436. Xenobiotica. 2006. PMID: 16864506

3

ECG changes and plasma concentrations of propafenone and its metabolites in a case of severe poisoning.

Fonck K, Haenebalcke C, Hemeryck A, Belpaire F, Jordaens L, Calle P, Buylaert W. Fonck K, et al. Among authors: hemeryck a. J Toxicol Clin Toxicol. 1998;36(3):247-51. doi: 10.3109/15563659809028948. J Toxicol Clin Toxicol. 1998. PMID: 9656983

4

Tissue distribution and depletion kinetics of bortezomib and bortezomib-related radioactivity in male rats after single and repeated intravenous injection of 14 C-bortezomib.

Hemeryck A, Geerts R, Monbaliu J, Hassler S, Verhaeghe T, Diels L, Verluyten W, van Beijsterveldt L, Mamidi RN, Janssen C, De Coster R. Hemeryck A, et al. Cancer Chemother Pharmacol. 2007 Nov;60(6):777-87. doi: 10.1007/s00280-007-0424-9. Epub 2007 Feb 7. Cancer Chemother Pharmacol. 2007. PMID: 17285316

5

Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (postexposure) rhesus monkey model.

Kao LM, Bush K, Barnewall R, Estep J, Thalacker FW, Olson PH, Drusano GL, Minton N, Chien S, Hemeryck A, Kelley MF. Kao LM, et al. Among authors: hemeryck a. Antimicrob Agents Chemother. 2006 Nov;50(11):3535-42. doi: 10.1128/AAC.00090-06. Antimicrob Agents Chemother. 2006. PMID: 17065619 Free PMC article.

6

Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update.

Hemeryck A, Belpaire FM. Hemeryck A, et al. Curr Drug Metab. 2002 Feb;3(1):13-37. doi: 10.2174/1389200023338017. Curr Drug Metab. 2002. PMID: 11876575 Review.

7

Population pharmacokinetic analysis of pegylated human erythropoietin in rats.

Jolling K, Ruixo JJ, Hemeryck A, Piotrovskij V, Greway T. Jolling K, et al. Among authors: hemeryck a. J Pharm Sci. 2004 Dec;93(12):3027-38. doi: 10.1002/jps.20200. J Pharm Sci. 2004. PMID: 15503315

8

In vitro studies on the metabolism of trabectedin (YONDELIS) in monkey and man, including human CYP reaction phenotyping.

Vermeir M, Hemeryck A, Cuyckens F, Francesch A, Bockx M, Van Houdt J, Steemans K, Mannens G, Avilés P, De Coster R. Vermeir M, et al. Among authors: hemeryck a. Biochem Pharmacol. 2009 May 15;77(10):1642-54. doi: 10.1016/j.bcp.2009.02.020. Epub 2009 Mar 10. Biochem Pharmacol. 2009. PMID: 19426702

9

Paroxetine affects metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.

Hemeryck A, Lefebvre RA, De Vriendt C, Belpaire FM. Hemeryck A, et al. Clin Pharmacol Ther. 2000 Mar;67(3):283-91. doi: 10.1067/mcp.2000.104788. Clin Pharmacol Ther. 2000. PMID: 10741632 Clinical Trial.

10

Mixed-effects modelling of the interspecies pharmacokinetic scaling of pegylated human erythropoietin.

Jolling K, Perez Ruixo JJ, Hemeryck A, Vermeulen A, Greway T. Jolling K, et al. Among authors: hemeryck a. Eur J Pharm Sci. 2005 Apr;24(5):465-75. doi: 10.1016/j.ejps.2005.01.002. Eur J Pharm Sci. 2005. PMID: 15784336

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page